BUSINESS
Moderna Eyes Bivalent Booster Rollout This Fall via Emergency Approval Path in Japan: CMO
Moderna is looking to introduce its Omicron-specific COVID-19 vaccine booster in Japan this autumn by tapping the country’s recently established emergency approval pathway, Chief Medical Officer Paul Burton said at a media briefing on May 27. The US company is…
To read the full story
Related Article
- Moderna Files Omicron Bivalent Vaccine in Japan
August 10, 2022
BUSINESS
- Nippon Kayaku’s Avastin Biosimilar Share Hits 58%
February 3, 2026
- Japan’s 1st OTC Morning-After Pill Now Available
February 3, 2026
- Amgen Ends Rocatinlimab Pact with Kyowa Kirin
February 3, 2026
- AstraZeneca Names Andy Barnett as New Japan President
February 3, 2026
- Shionogi Eyes Faster QOL Biz Expansion with Ex-JT Researchers: CEO
February 2, 2026
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…





